A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2004
12/23/2004	WO2004111250A1 Recombinant adeno-associated virus vector for treatment of alzheimer disease
12/23/2004	WO2004111248A2 Improved aav vector for gene therapy
12/23/2004	WO2004111247A1 Circular expression construct for gene therapeutic applications
12/23/2004	WO2004111238A1 Transcription regulatory sequence
12/23/2004	WO2004111195A2 Methods and use of zona-free therapeutic cloning
12/23/2004	WO2004111191A2 Methods and compositions for controlling efficacy of rna silencing
12/23/2004	WO2004111082A2 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof
12/23/2004	WO2004111074A2 In vivo production of a clostridial neurotoxin light chain peptide
12/23/2004	WO2004110980A1 Sphingolipids' polyalkylamines conjugates
12/23/2004	WO2004110603A2 Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions
12/23/2004	WO2004110533A1 Needleless syringe having medical agent accommodated therein
12/23/2004	WO2004110499A1 Sphingolipids polyalkylamine conjugates for use in transfection
12/23/2004	WO2004110496A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004	WO2004110476A1 Pharmaceutcal composition for treating or preventing disorders of blood-brain barrier
12/23/2004	WO2004110474A1 Pharmaceutical composition for inducing apoptosis comprising a fusion protein between bfl-1 and green fluorescent protein or a gene encoding same
12/23/2004	WO2004110471A1 Preventive or remedy for disease associated with apoptosis
12/23/2004	WO2004110372A2 Room temperature storage of organs
12/23/2004	WO2004110371A2 Method for the treatment of malignancies
12/23/2004	WO2004097039A9 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue
12/23/2004	WO2004076623A3 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth
12/23/2004	WO2004072269A3 Bex4 nucleic acids, polypeptides, and method of using
12/23/2004	WO2004071429A3 Lung inflammation treatment
12/23/2004	WO2004067706A3 Production of multimeric proteins
12/23/2004	WO2004063356A3 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
12/23/2004	WO2004045563A3 Method of treatment of myocardial infarction
12/23/2004	WO2003097805A3 Delivery of nucleic acid-like compounds
12/23/2004	WO2003077852A8 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β
12/23/2004	WO2003050236A3 Human genes and gene expression products isolated from human prostate
12/23/2004	US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease
12/23/2004	US20040260115 Polymers for the delivery of bioactive agents and methods of their preparation
12/23/2004	US20040260079 Cardiac-cell specific enhancer elements and uses thereof
12/23/2004	US20040260061 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity
12/23/2004	US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay
12/23/2004	US20040259828 Intravascular delivery of non-viral nucleic acid
12/23/2004	US20040259825 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides
12/23/2004	US20040259823 Cationic amphiphiles as transfection vehicles
12/23/2004	US20040259822 Antibody which recognizes epitope containing nucleic acid coupled to active protein; hybridomas
12/23/2004	US20040259778 Utilization of histamine receptor h3 gene participating in body weight or food intake control
12/23/2004	US20040259774 Nucleotide sequences; binding to antibodies
12/23/2004	US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents
12/23/2004	US20040259248 RNA interference mediating small RNA molecules
12/23/2004	US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference)
12/23/2004	US20040259208 Such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040259199 32544, Novel human phospholipase C and uses thereof
12/23/2004	US20040259196 T cell receptor variants expressed in mesenchymal cells and uses thereof
12/23/2004	US20040259195 Anti-cellular proliferative disorder polypeptide
12/23/2004	US20040259160 drug screening for agents that induce glucose-stimulated insulin production to treat type-2 diabetes; "beta-TRP" polypeptide refers to a calcium channel; transforming islet cells with expression cassettes encoding beta-TRP into diabetic islet cells to improve glucose-stimulated insulin production
12/23/2004	US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040259097 Method for the in vitro synthesis of short double stranded rnas
12/23/2004	US20040259084 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
12/23/2004	US20040258715 Porcine circoviruses, vaccines and diagnostic reagents
12/23/2004	US20040258709 Hepatitis B virus polypeptides
12/23/2004	US20040258698 Delivery of immune response modifier compounds
12/23/2004	US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer
12/23/2004	US20040258686 Mammalian receptor proteins; related reagents and methods
12/23/2004	US20040258673 Elective collection and banking of autologous peripheral blood stem cells
12/23/2004	US20040258672 Graft acceptance through manipulation of thymic regeneration
12/23/2004	US20040258671 Delivering antiinflammatory cytokines to nervous system using gene therapy techniques
12/23/2004	US20040258670 Introducing enriched human endothelial generating cells and mesenchymal stem cells; enhancing vasculogenesis and collateralization around blocked and/or narrowed vessels
12/23/2004	US20040258668 Using nonsteroidal antiinflammatory drugs and/or muscle relaxants; supressing cytotoxicity during gene therapy
12/23/2004	US20040258667 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/23/2004	US20040258666 Injecting adeno-associated virus vectors into central nervous system; transducing cells located at distal site for translation of biologically active molecule and expression; Niemann-Pick A disease
12/23/2004	US20040258665 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
12/23/2004	US20040258660 Tumor necrosis factor alpha analogues having three dimensional structure of similar to proteins from which they are derived; facilitating correct folding
12/23/2004	US20040258616 Compositions and methods for treating cancer using IGSF9 and LIV-1
12/23/2004	CA2528402A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004	CA2528240A1 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof
12/23/2004	CA2528012A1 Methods and compositions for controlling efficacy of rna silencing
12/23/2004	CA2527954A1 Modified fiber proteins for efficient receptor binding
12/23/2004	CA2527869A1 Method for the treatment of malignancies
12/23/2004	CA2527822A1 Room temperature storage of organs
12/23/2004	CA2527361A1 Novel modified corin molecules having substitute activation sequences and uses thereof
12/23/2004	CA2525784A1 Proteoglycan degrading mutants for treatment of cns
12/23/2004	CA2525782A1 Degradation of glycosaminoglycans in extracellular matrix to treat cns injury
12/23/2004	CA2525017A1 Needleless syringe having medical agent accommodated therein
12/23/2004	CA2519875A1 Method of tumor regression with vegf inhibitors
12/22/2004	EP1489189A1 Diagnostics and remedies for malignant brain tumor
12/22/2004	EP1489185A1 Methods and compositions for use in splicesome mediated rna trans-splicing
12/22/2004	EP1489184A1 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
12/22/2004	EP1489172A1 Nuclear receptor err gamma 3
12/22/2004	EP1489171A1 Functional molecule and process for producing the same
12/22/2004	EP1489164A1 Recombinant vaccinia viruses with modified F3 genes, uses thereof
12/22/2004	EP1489126A1 Polymers for the delivery of bioactive agents and methods of their preparation
12/22/2004	EP1488761A1 Device for delivering a therapeutic agent to a blood vessel
12/22/2004	EP1488239A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
12/22/2004	EP1487998A2 Methods for diagnosing and treating schizophrenia
12/22/2004	EP1487992A2 Central airway administration for systemic delivery of therapeutics
12/22/2004	EP1487986A2 METHOD OF PREPARING A TREATMENT PRODUCT, TREATMENT PRODUCT AND A PLASMID CONSTRUCT
12/22/2004	EP1487984A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
12/22/2004	EP1487983A2 Prevention of recurrence and metastasis of cancer
12/22/2004	EP1487981A2 Growth regulating proteins
12/22/2004	EP1487976A2 Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides
12/22/2004	EP1487970A2 Tolerogenic antigen-presenting cells
12/22/2004	EP1487964A2 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL ALPHA-SUBUNIT, K+alphaM1, AND VARIANTS THEREOF
12/22/2004	EP1487865A2 USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS
12/22/2004	EP1487857A1 Lymphatic and blood endothelial cell genes
12/22/2004	EP1487855A2 Method of using modified oligonucleotides for hepatic delivery
12/22/2004	EP1487788A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds

1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 870